Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer

Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany

VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer ( Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany )

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration...

Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer ( Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands )

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer

Dr Antonio González-Martín - Clínica Universidad de Navarra, Madrid, Spain

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer ( Dr Antonio González-Martín - Clínica Universidad de Navarra, Madrid, Spain )

IMspire170: New combination treatment for advanced melanoma

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

IMspire170: New combination treatment for advanced melanoma ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced...

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma

Dr Jonathan Ledermann - University College Hospital, London, UK

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma ( Dr Jonathan Ledermann - University College Hospital, London, UK )

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural...

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Checkmate 227: Final analysis for the non small cell lung cancer trial

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

Checkmate 227: Final analysis for the non small cell lung cancer trial ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

PARP inhibitors for metastatic breast cancer

Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany

PARP inhibitors for metastatic breast cancer ( Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )

KATHERINE trial updates for HER2-positive breast cancer

Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany

KATHERINE trial updates for HER2-positive breast cancer ( Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer

Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of...

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer ( Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Ireland )

More from ecancer